Sarepta Therapeutics | SRPT - 普通股股本

金融业

USD

USD 3.18B

现金及等价物

USD 464.45M

USD 109.46M

USD 2.31B

USD 499.16M

USD 1.04B

USD 358.43M

USD -252.2M

1.37K

EPS每股收益

USD 3.16

股本和储备

USD 1.51B

USD 621.34M

债务利息支出

USD 20.84M

USD 8.74M

USD 838.16M

USD 1.59B

USD 330.96M

USD 372.37M

USD 358.43M

普通股股本

USD 105.57M

27.27

USD 343.17M

USD 730.8M

销售和管理费用

USD 54.03M

USD 1B

贸易债权人

USD 70.38M

应收帐款人

USD 547.91M

	普通股股本	更改		日
Acadia Pharmaceuticals	USD 169.18M		470K	2025-12
Agios Pharmaceuticals	USD 59.34M		892K	2026-03
Alnylam Pharmaceuticals	USD 133.44M		1.07M	2026-03
Amgen	USD 540M		1000K	2026-03
BioCryst Pharmaceuticals	USD 213.06M		2.54M	2025-12
Biogen	USD 146.7M		200K	2025-09
BioMarin Pharmaceutical	USD 193.27M		969K	2026-03
Capricor Therapeutics	USD 57.37M		11.65M	2025-12
Daiichi Sankyo	JPY 1.85B		9K	2025-12
Eli Lilly	USD 943.5M		3.33M	2026-03
Esperion Therapeutics	USD 245.22M		39.79M	2025-12
Gilead Sciences	USD 1.24B		1000K	2026-03
Incyte	USD 199.95M		1.49M	2026-03
Insmed	USD 216.52M		2.27M	2026-03
Ionis Pharmaceuticals	USD 165.9M		3.93M	2026-03
Moderna	USD 391M		2M	2025-09
Nektar Therapeutics	USD 20.38M		20.36M	2025-12
Neurocrine Biosciences	USD 100.6M		500K	2026-03
Novavax	USD 162.58M		106K	2025-12
Pfizer	USD 5.7B		13M	2026-03
PTC Therapeutics	USD 81.47M		1.54M	2025-12
Regeneron Pharmaceuticals	USD 105M		300K	2026-03
Roche Holding	CHF 795.62M		699.54K	2025-12
Sanofi	EUR 1.21B		8.25M	2026-03
Sarepta Therapeutics	USD 105.57M		607K	2026-03
Tectonic Therapeutic	USD 18.74M		25.03K	2025-12
Ultragenyx Pharmaceutical	USD 98.3M		1.7M	2026-03
Vertex Pharmaceuticals	USD 254.2M		200K	2026-03